Hip Involvement in Juvenile Idiopathic Arthritis: A Roadmap From Arthritis to Total Hip Arthroplasty or How Can We Prevent Hip Damage?

Objectives: To describe the clinical characteristics of hip involvement in juvenile idiopathic arthritis (JIA) from arthritis to hip osteoarthritis (HOA) and total hip arthroplasty (THA).Study Design: Seven hundred fifty-three patients aged 2–17 years with JIA were included in the study. The compari...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lubov S. Sorokina, Ilia S. Avrusin, Rinat K. Raupov, Natalia A. Lubimova, Sergey V. Khrypov, Mikhail M. Kostik
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/c9622ba82602400fb19f3b5f526649c7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c9622ba82602400fb19f3b5f526649c7
record_format dspace
spelling oai:doaj.org-article:c9622ba82602400fb19f3b5f526649c72021-11-05T11:08:08ZHip Involvement in Juvenile Idiopathic Arthritis: A Roadmap From Arthritis to Total Hip Arthroplasty or How Can We Prevent Hip Damage?2296-236010.3389/fped.2021.747779https://doaj.org/article/c9622ba82602400fb19f3b5f526649c72021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fped.2021.747779/fullhttps://doaj.org/toc/2296-2360Objectives: To describe the clinical characteristics of hip involvement in juvenile idiopathic arthritis (JIA) from arthritis to hip osteoarthritis (HOA) and total hip arthroplasty (THA).Study Design: Seven hundred fifty-three patients aged 2–17 years with JIA were included in the study. The comparison analysis was performed between the following subgroups: (i) JIA without hip involvement (n = 600; 79.7%) vs. JIA with hip involvement without HOA (n = 105; 13.9%), (ii) JIA with hip involvement with HOA, but without THA (n = 32; 4.3%) and JIA with hip involvement with HOA and with THA (n = 16; 2.1%). Clinical, laboratory characteristics and treatment regimens compared.Results: Hip involvement was present in 20.3% of patients. HOA was present in 6.4% (12*1,000 patient-years) of the entire JIA group and 31.4% of patients with hip involvement. Sixteen patients (2.1%; 4.0*1,000 patient-years) required THA. The following factors were associated with HOA: sJIA (OR = 3.6, p = 0.008; HR = 3.0, p = 0.002), delayed remission (OR = 4.2, p = 0.004; HR = 1.4, p = 0.538), delay in biologic therapy initiation (OR = 7.5, p = 0.00001; HR = 6.7, p = 0.002), alkaline phosphatase <165 U\l (OR = 4.1, p = 0.0003; HR = 5.2, p = 0.000004), treatment with corticosteroids (CS) (OR = 2.6, p = 0.008; HR = 1.2, p = 0.670), cumulative corticosteroids >2,700 mg (OR = 4.3, p = 0.032; HR = 1.4, p = 0.527). The following factors were associated with THA: delay in biologic treatment initiation (OR = 1.04, p = 0.0001; HR = 9.1, p = 0.034), delayed hip involvement (OR = 5.2, p = 0.002; HR = 3.0, p = 0.044), and methylprednisolone pulse therapy (OR = 10.8, p = 0.0000001; HR = 5.6, p = 0.002).Conclusion: Both sJIA and systemic CS, impaired calcium-phosphorus metabolism, and delayed hip arthritis are associated with HOA development in JIA. HOA is considered to be a severe adverse event of CS treatment, especially delayed hip involvement.Lubov S. SorokinaIlia S. AvrusinRinat K. RaupovRinat K. RaupovRinat K. RaupovNatalia A. LubimovaSergey V. KhrypovMikhail M. KostikMikhail M. KostikFrontiers Media S.A.articlejuvenile idiopathic arthritiship osteoarthritistotal hip arthroplastycorticosteroidsavascular osteonecrosis of the femoral headPediatricsRJ1-570ENFrontiers in Pediatrics, Vol 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic juvenile idiopathic arthritis
hip osteoarthritis
total hip arthroplasty
corticosteroids
avascular osteonecrosis of the femoral head
Pediatrics
RJ1-570
spellingShingle juvenile idiopathic arthritis
hip osteoarthritis
total hip arthroplasty
corticosteroids
avascular osteonecrosis of the femoral head
Pediatrics
RJ1-570
Lubov S. Sorokina
Ilia S. Avrusin
Rinat K. Raupov
Rinat K. Raupov
Rinat K. Raupov
Natalia A. Lubimova
Sergey V. Khrypov
Mikhail M. Kostik
Mikhail M. Kostik
Hip Involvement in Juvenile Idiopathic Arthritis: A Roadmap From Arthritis to Total Hip Arthroplasty or How Can We Prevent Hip Damage?
description Objectives: To describe the clinical characteristics of hip involvement in juvenile idiopathic arthritis (JIA) from arthritis to hip osteoarthritis (HOA) and total hip arthroplasty (THA).Study Design: Seven hundred fifty-three patients aged 2–17 years with JIA were included in the study. The comparison analysis was performed between the following subgroups: (i) JIA without hip involvement (n = 600; 79.7%) vs. JIA with hip involvement without HOA (n = 105; 13.9%), (ii) JIA with hip involvement with HOA, but without THA (n = 32; 4.3%) and JIA with hip involvement with HOA and with THA (n = 16; 2.1%). Clinical, laboratory characteristics and treatment regimens compared.Results: Hip involvement was present in 20.3% of patients. HOA was present in 6.4% (12*1,000 patient-years) of the entire JIA group and 31.4% of patients with hip involvement. Sixteen patients (2.1%; 4.0*1,000 patient-years) required THA. The following factors were associated with HOA: sJIA (OR = 3.6, p = 0.008; HR = 3.0, p = 0.002), delayed remission (OR = 4.2, p = 0.004; HR = 1.4, p = 0.538), delay in biologic therapy initiation (OR = 7.5, p = 0.00001; HR = 6.7, p = 0.002), alkaline phosphatase <165 U\l (OR = 4.1, p = 0.0003; HR = 5.2, p = 0.000004), treatment with corticosteroids (CS) (OR = 2.6, p = 0.008; HR = 1.2, p = 0.670), cumulative corticosteroids >2,700 mg (OR = 4.3, p = 0.032; HR = 1.4, p = 0.527). The following factors were associated with THA: delay in biologic treatment initiation (OR = 1.04, p = 0.0001; HR = 9.1, p = 0.034), delayed hip involvement (OR = 5.2, p = 0.002; HR = 3.0, p = 0.044), and methylprednisolone pulse therapy (OR = 10.8, p = 0.0000001; HR = 5.6, p = 0.002).Conclusion: Both sJIA and systemic CS, impaired calcium-phosphorus metabolism, and delayed hip arthritis are associated with HOA development in JIA. HOA is considered to be a severe adverse event of CS treatment, especially delayed hip involvement.
format article
author Lubov S. Sorokina
Ilia S. Avrusin
Rinat K. Raupov
Rinat K. Raupov
Rinat K. Raupov
Natalia A. Lubimova
Sergey V. Khrypov
Mikhail M. Kostik
Mikhail M. Kostik
author_facet Lubov S. Sorokina
Ilia S. Avrusin
Rinat K. Raupov
Rinat K. Raupov
Rinat K. Raupov
Natalia A. Lubimova
Sergey V. Khrypov
Mikhail M. Kostik
Mikhail M. Kostik
author_sort Lubov S. Sorokina
title Hip Involvement in Juvenile Idiopathic Arthritis: A Roadmap From Arthritis to Total Hip Arthroplasty or How Can We Prevent Hip Damage?
title_short Hip Involvement in Juvenile Idiopathic Arthritis: A Roadmap From Arthritis to Total Hip Arthroplasty or How Can We Prevent Hip Damage?
title_full Hip Involvement in Juvenile Idiopathic Arthritis: A Roadmap From Arthritis to Total Hip Arthroplasty or How Can We Prevent Hip Damage?
title_fullStr Hip Involvement in Juvenile Idiopathic Arthritis: A Roadmap From Arthritis to Total Hip Arthroplasty or How Can We Prevent Hip Damage?
title_full_unstemmed Hip Involvement in Juvenile Idiopathic Arthritis: A Roadmap From Arthritis to Total Hip Arthroplasty or How Can We Prevent Hip Damage?
title_sort hip involvement in juvenile idiopathic arthritis: a roadmap from arthritis to total hip arthroplasty or how can we prevent hip damage?
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/c9622ba82602400fb19f3b5f526649c7
work_keys_str_mv AT lubovssorokina hipinvolvementinjuvenileidiopathicarthritisaroadmapfromarthritistototalhiparthroplastyorhowcanwepreventhipdamage
AT iliasavrusin hipinvolvementinjuvenileidiopathicarthritisaroadmapfromarthritistototalhiparthroplastyorhowcanwepreventhipdamage
AT rinatkraupov hipinvolvementinjuvenileidiopathicarthritisaroadmapfromarthritistototalhiparthroplastyorhowcanwepreventhipdamage
AT rinatkraupov hipinvolvementinjuvenileidiopathicarthritisaroadmapfromarthritistototalhiparthroplastyorhowcanwepreventhipdamage
AT rinatkraupov hipinvolvementinjuvenileidiopathicarthritisaroadmapfromarthritistototalhiparthroplastyorhowcanwepreventhipdamage
AT nataliaalubimova hipinvolvementinjuvenileidiopathicarthritisaroadmapfromarthritistototalhiparthroplastyorhowcanwepreventhipdamage
AT sergeyvkhrypov hipinvolvementinjuvenileidiopathicarthritisaroadmapfromarthritistototalhiparthroplastyorhowcanwepreventhipdamage
AT mikhailmkostik hipinvolvementinjuvenileidiopathicarthritisaroadmapfromarthritistototalhiparthroplastyorhowcanwepreventhipdamage
AT mikhailmkostik hipinvolvementinjuvenileidiopathicarthritisaroadmapfromarthritistototalhiparthroplastyorhowcanwepreventhipdamage
_version_ 1718444315548581888